Summary & Overview
CPT 81410: Genomic Sequencing for Heritable Thoracic Aortic Disease
CPT code 81410 is a genomic sequencing procedure targeting heritable thoracic aortic diseases, including Marfan syndrome, Loeys-Dietz syndrome, Ehlers-Danlos syndrome type IV, and arterial tortuosity syndrome. This code is significant nationally as it enables precise molecular diagnosis for patients with suspected genetic aortic disorders, facilitating early intervention and tailored management. The procedure is typically performed in laboratory settings, either independent or hospital-based, and is recognized by major payers such as Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare.
This publication provides a comprehensive overview of 81410, including payer coverage, clinical context, and policy updates. Readers will gain insight into current benchmarks for genomic sequencing in thoracic aortic disease, understand payer-specific considerations, and review the latest developments in molecular pathology billing. The article also highlights the importance of accurate coding and documentation for laboratory services, ensuring compliance with payer requirements. By examining the role of 81410 in the broader landscape of genetic testing, the publication offers valuable information for stakeholders navigating the evolving field of precision medicine.
CPT Code Overview
CPT code 81410 represents a genomic sequencing procedure for heritable thoracic aortic disease. This includes conditions such as Marfan syndrome, Loeys-Dietz syndrome, Ehlers-Danlos syndrome type IV, and arterial tortuosity syndrome. The service type is genomic sequencing and molecular pathology, typically performed in a laboratory setting, such as an independent laboratory or hospital lab (commonly place of service codes 81 or 19). This procedure is used to identify genetic variants associated with thoracic aortic disease, supporting clinical diagnosis and management.
Clinical & Coding Specifications
Clinical Context
A patient presents with clinical features suggestive of a heritable thoracic aortic disease, such as Marfan syndrome, Loeys-Dietz syndrome, Ehlers-Danlos syndrome type IV, or arterial tortuosity syndrome. The provider, often a family medicine or internal medicine physician, refers the patient for genomic sequencing to confirm the diagnosis and guide management. The procedure is performed in a laboratory setting, such as an independent laboratory or hospital lab (typically Place of Service 81 or 19). The workflow involves specimen collection, laboratory analysis, and interpretation of results by a qualified professional.
Coding Specifications
-
Modifiers:
- Modifier
26: Used to indicate the professional component of the service, such as interpretation of the genomic sequencing results. - Modifier
TC: Used to indicate the technical component, which includes the laboratory processing and sequencing.
- Modifier
-
Provider Taxonomies:
| Taxonomy Code | Specialty Name |
|---|---|
291U00000X |